Cargando...
Restrictive access to clopidogrel and mortality following coronary stent implantation
BACKGROUND: In Canada, access to clopidogrel is restricted by most provincial drug insurance plans in order to contain costs. Until April 2007, the Régie de l'assurance maladie du Québec (RAMQ) Prescription Drug Insurance Plan reviewed special access forms before approving reimbursement for clo...
Gardado en:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Canadian Medical Association
2008
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2228353/ https://ncbi.nlm.nih.gov/pubmed/18268267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.070586 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|